Development of standard clinical endpoints for use in dengue interventional trials.

Autor: Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA)., Wills B; Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam., See Lum LC; Department of Paediatrics, University of Malaya, Kuala Lumpur, Malaysia., Thomas L; Emergency Department, University Hospital of Martinique, Fort-de-France, Martinique., Durbin A; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Leo YS; Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore., de Bosch N; Universidad Central de Venezuela, Caracas, Venezuela., Rojas E; Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia., Hendrickx K; FWO Postdoctoral Fellow of the Life Sciences & Society Lab, Center for Sociological Research, KU Leuven and Research Associate of SPIRAL Research Center, University of Liège, Belgium., Erpicum M; SPIRAL Research Center, University of Liège, Belgium., Agulto L; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA)., Jaenisch T; Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Tissera H; National Dengue Control Unit, Ministry of Health, Elvitigala Mawatha, Colombo, Sri Lanka., Suntarattiwong P; Department of Pediatrics, Queen Sirikit National Institute of Child Health, Bangkok, Thailand., Collers BA; Merck & Co. Inc., Kenilworth, New Jersey, United States of America., Wallace D; Takeda Pharmaceutical Co. Ltd., Zurich, Switzerland., Schmidt AC; GlaxoSmithKline plc (GSK) Vaccines, Rockville, Maryland, United States of America., Precioso A; Division of Clinical Trials and Pharmacovigilance, Butantan Institute, São Paulo, Brazil.; Pediatrics Department of the Medical School of University of São Paulo, São Paulo, Brazil., Narvaez F; Infectious Diseases Unit, National Pediatric Reference Hospital, Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua., Thomas SJ; Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, New York, United States of America., Edelman R; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Siqueira JB; Federal University of Goias, Brasilia, Brazil., Cassetti MC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA)., Dempsey W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America (USA)., Gubler DJ; Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Oct 04; Vol. 12 (10), pp. e0006497. Date of Electronic Publication: 2018 Oct 04 (Print Publication: 2018).